The BioAccord LC-MS System with ACQUITY Premier is designed specifically for routine monitoring in biopharmaceutical process and product development.
• Rapid and confident decisions driven by accessible, high quality data
• Simplicity, consistency and productivity ensured by automation
• Relevant information provided by biotherapeutic analysis workflows and methods
• Compliant-ready platform that can be deployed from discovery to GxP labs
• Rapid deployment and return on investment
• Small system footprint
Why Adopt LC-MS?
• Productivity is increased as a range different analyses can be performed on the same system, replacing multiple conventional analytical techniques
• Multi-attribute methods can be deployed that reduce the number of analyses required to monitor biotherapeutic quality
• It is a sensitive technique that allows detection of low level analytes and impurities
• It provides information-rich data that helps guide decision-making
Delivering Consistent, High Quality Data
Fully automated system set-up and an intelligent health system that continuously monitors system performance ensure that:
• The system is always producing data of the required quality
• Data quality is consistent from user to user and system to system
• Any issues are rapidly diagnosed and resolved
Dedicated Application Workflows
The system has tailored workflows for:
• CONFIRM Sequence
• Intact mass analysis (proteins, nucleic acids, synthetic peptides)
• Peptide mapping
• Peptide MAM (multi-attribute method)
• Released N-glycan analysis
Oligonucleotide sequence confirmation
Impurity analysis for proteins, peptides, and oligonucleotides